Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jul;58(7):1583-1587.
doi: 10.1111/trf.14636. Epub 2018 Apr 17.

Peripartum Management of HLA Alloimmune Platelet Refractoriness

Affiliations
Case Reports

Peripartum Management of HLA Alloimmune Platelet Refractoriness

Jeremy Ryan Peña et al. Transfusion. .

Abstract

Background: Platelet (PLT) refractoriness presents a challenging problem for transfusion support, especially in the perioperative setting, where there is urgency for human leukocyte antigen (HLA)-compatible units, yet identification and provision of compatible PLT concentrates requires time.

Case report: A 22-year-old G3P1 woman with thrombocytopenia due to aplastic anemia, likely autoimmune, presented in her third trimester for peripartum care and newly diagnosed HLA alloimmune PLT refractoriness. Despite early planning, the patient developed bleeding requiring urgent delivery. Notably, the patient also developed strong allele-specific HLA antibody, precluding the use of HLA-matched PLTs.

Results: Using full-range HLA testing services and multidisciplinary physician planning, several HLA-compatible PLT concentrates were procured to support her peripartum bleeding.

Conclusion: We describe what appears to be the first reported case of management of transfusion support of PLT refractoriness peripartum. Although complicated by allele-specific HLA antibodies, using a combination of acceptable low-level antibodies and crossmatching we successfully identified HLA-compatible PLT concentrates resulting in posttransfusion PLT count increments.

Similar articles

See all similar articles

References

REFERENCES

    1. Peña JR, Saidman SL, Girouard TC, et al. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion. Am J Hematol 2014; 89:E133-7.
    1. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009;49:1825-35.
    1. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009;114:1326-31.
    1. Kopko PM, Warner P, Kresie L, et al. Methods for the selection of platelet products for alloimmune-refractory patients. Transfusion 2015;55:235-44.
    1. Taaning E. HLA antibodies and fetomaternal alloimmune thrombocytopenia: myth or meaningful? Transfus Med Rev 2000; 14:275-80.

Publication types

LinkOut - more resources

Feedback